CERT 240816 15.00C (CERT240816C15000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CERT240816C15000

Watchlist

2.60
+0.40+18.18%

15min DelayTrading Jul 26 10:01 ET

2.60High2.60Low

Intraday

5D
Daily

News

Express News | Certara Inc : Leerink Partners Cuts Target Price to $16 From $19
ReutersJul 15 05:56 ET
KeyBanc Maintains Certara(CERT.US) With Buy Rating, Cuts Target Price to $20
Moomoo NewsJul 11 11:31 ET · Ratings
A Quick Look at Today's Ratings for Certara(CERT.US), With a Forecast Between $16 to $21
Moomoo NewsJul 11 09:00 ET · Ratings
Certara Price Target Cut to $20.00/Share From $23.00 by Keybanc
Dow JonesJul 11 07:19 ET
Certara Is Maintained at Overweight by Keybanc
Dow JonesJul 11 07:19 ET
Express News | Keybanc Maintains Overweight on Certara, Lowers Price Target to $20
BenzingaJul 11 07:09 ET

Comments

Moomoo AI

Mar 21 09:18

The fact that Certara is now generating some pre-tax profits from its prior investments is very encouraging. The promising trends warrant this stock for further investigation despite its current low returns compared to the industry average.

Returns At Certara (NASDAQ:CERT) Are On The Way Up

Moomoo AI

Dec 13, 2023 15:33

Acquisition of Applied BioMath by Certara could enhance QSP biosimulation adoption in life sciences, revolutionizing drug invention. This may impact the drug discovery process, improving decisions and reducing late stage attrition rates.

Press Release: Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

Moomoo AI

Oct 31, 2023 06:27

Amid less promising revenue projections, Certara's surprisingly high P/S ratio indicates investor hopes for a business rebound. However, analysts remain skeptical, suggesting shareholders may face disappointment if the P/S ratio rebalances with growth outlook.

Certara, Inc.'s (NASDAQ:CERT) Price Is Out Of Tune With Revenues

Movers and Shakers

Aug 22, 2023 07:21

Columns Today's Pre-Market Stock Movers And Top Ratings: ZM, LOW, EMR, MDT and More

Pre-Market Stock Movers
Gapping up
$Fabrinet(FN.US)$
(Fabrinet surged 21% after its fiscal fourth-quarter results late Monday topped analysts' estimates. The advanced manufacturing services company posted non-GAAP earnings of $1.86 per share, greater than the $1.80 earnings per share expected by analysts polled by FactSet. Revenue came in at $655.9 million, greater than the $641.4 million consensus estimate.)
$Applovin(APP.US)$
...